| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. | Chief Operating Officer | Common Stock | 172K | $1.72M | $9.98 | Mar 3, 2025 | Direct |
| Cyclerion Therapeutics, Inc. | Chief Operating Officer | Employee Stock Option (Right to Buy) | 135K | Jan 20, 2022 | Direct | ||
| Rapport Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 129K | Feb 3, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| RAPP | Rapport Therapeutics, Inc. | Mar 3, 2025 | 1 | $0 | 4 | Mar 5, 2025 | Chief Operating Officer |
| RAPP | Rapport Therapeutics, Inc. | Feb 3, 2025 | 1 | $0 | 4 | Feb 4, 2025 | Chief Operating Officer |
| RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Chief Operations Officer |
| RAPP | Rapport Therapeutics, Inc. | Jun 6, 2024 | 0 | $0 | 3 | Jun 6, 2024 | Chief Operations Officer |
| CYCN | Cyclerion Therapeutics, Inc. | Jan 20, 2022 | 1 | $0 | 4 | Jan 24, 2022 | Chief Operating Officer |
| CYCN | Cyclerion Therapeutics, Inc. | Dec 9, 2021 | 1 | $0 | 4 | Dec 10, 2021 | Chief Operating Officer |